Literature DB >> 21692777

Midline axon guidance and human genetic disorders.

L Izzi1, F Charron.   

Abstract

In bilaterally symmetric animals, many axons cross the midline to interconnect the left and right sides of the central nervous system (CNS). This process is critical for the establishment of neural circuits that control the proper integration of information perceived by the organism and the resulting response. While neurons at different levels of the CNS project axons across the midline, the molecules that regulate this process are common to many if not all midline-crossing regions. This article reviews the molecules that function as guidance cues at the midline in the developing vertebrate spinal cord, cortico-spinal tract and corpus callosum. As well, we describe the mutations that have been identified in humans that are linked to axon guidance and midline-crossing defects. 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21692777     DOI: 10.1111/j.1399-0004.2011.01735.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  23 in total

1.  Behavioral Consequences of a Bifacial Map in the Mouse Somatosensory Cortex.

Authors:  Vassiliy Tsytsarev; Hiroyuki Arakawa; Shuxin Zhao; Alain Chédotal; Reha S Erzurumlu
Journal:  J Neurosci       Date:  2017-06-29       Impact factor: 6.167

Review 2.  Midline axon guidance in the Drosophila embryonic central nervous system.

Authors:  LaFreda J Howard; Haley E Brown; Benjamin C Wadsworth; Timothy A Evans
Journal:  Semin Cell Dev Biol       Date:  2017-11-27       Impact factor: 7.727

Review 3.  Human disorders of axon guidance.

Authors:  Alicia A Nugent; Adrianne L Kolpak; Elizabeth C Engle
Journal:  Curr Opin Neurobiol       Date:  2012-03-05       Impact factor: 6.627

4.  Undecussated superior cerebellar peduncles and absence of the dorsal transverse pontine fibers: a new axonal guidance disorder?

Authors:  Charlotte F Kweldam; Hilary Gwynn; Alpa Vashist; Alexander H Hoon; Thierry A G M Huisman; Andrea Poretti
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

5.  Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks.

Authors:  Vijay K Ramanan; Sungeun Kim; Kelly Holohan; Li Shen; Kwangsik Nho; Shannon L Risacher; Tatiana M Foroud; Shubhabrata Mukherjee; Paul K Crane; Paul S Aisen; Ronald C Petersen; Michael W Weiner; Andrew J Saykin
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

Review 6.  Actin dynamics in growth cone motility and navigation.

Authors:  Timothy M Gomez; Paul C Letourneau
Journal:  J Neurochem       Date:  2013-11-17       Impact factor: 5.372

7.  Frizzled3 Controls Axonal Polarity and Intermediate Target Entry during Striatal Pathway Development.

Authors:  Francesca Morello; Asheeta A Prasad; Kati Rehberg; Renata Vieira de Sá; Noelia Antón-Bolaños; Eduardo Leyva-Diaz; Youri Adolfs; Fadel Tissir; Guillermina López-Bendito; R Jeroen Pasterkamp
Journal:  J Neurosci       Date:  2015-10-21       Impact factor: 6.167

Review 8.  White matter abnormalities in fetal alcohol spectrum disorders: Focus on axon growth and guidance.

Authors:  Erin Mathews; Kevyn Dewees; Deborah Diaz; Carlita Favero
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-10

9.  Netrin-1 stimulates developing GnRH neurons to extend neurites to the median eminence in a calcium- dependent manner.

Authors:  Victoria F Low; Zeno Fiorini; Lorryn Fisher; Christine L Jasoni
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

10.  Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration.

Authors:  Gabriella Passacquale; Alkystis Phinikaridou; Christina Warboys; Margaret Cooper; Begona Lavin; Alessio Alfieri; Marcelo E Andia; Rene M Botnar; Albert Ferro
Journal:  Br J Pharmacol       Date:  2015-06-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.